YMB declares honoraria for lectures from AstraZeneca and Sanofi Aventis; and has participated in advisory boards for Boehringer Ingelheim, Novo Nordisk, and Sanofi Aventis. EST declares honoraria from Merck Sharp and Dohme (Singapore), Amgen, Novartis, and Novo Nordisk; and owns stock in Abbott Laboratories. TYW declares consultancy fees from Bayer, Boehringer Ingelheim, Eden Ophthalmic, Genentech, Iveric Bio, Merck, Novartis, Oxurion, Plano, Roche, Samsung, Shanghai Henlius, and Zhaoke Pharmacecutical; holds patents; and is a cofounder EyRiS and Visre, which have interests in developing digital solutions for eye diseases, including diabetic retinopathy.